This inventor holds 2 USPTO granted patents. Top assignees: Amgen Inc., Tularik Limited. Active years: 2004-2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004-2006
Title: The Innovations of Stephen Joseph Shuttleworth
Introduction
Stephen Joseph Shuttleworth is an accomplished inventor based in Foster City, CA (US). He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that target G-protein coupled receptors. With a total of 2 patents to his name, Shuttleworth's work has the potential to impact the treatment of various medical conditions.
Latest Patents
Shuttleworth's latest patents focus on fused heterocyclic compounds. The first patent provides compounds with a specific formula that are useful in treating or preventing conditions mediated by G-protein coupled receptors. These conditions include eating disorders, obesity, anxiety disorders, and mood disorders. The pharmaceutical compositions and methods outlined in his patents offer innovative approaches to addressing these health issues.
Career Highlights
Throughout his career, Shuttleworth has worked with notable companies such as Tularik Limited and Amgen Inc. His experience in these organizations has allowed him to refine his expertise in drug development and innovation. His contributions have been instrumental in advancing the understanding and treatment of complex medical conditions.
Collaborations
Shuttleworth has collaborated with talented individuals in his field, including Xiaoqi Chen and Pingchen Fan. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Stephen Joseph Shuttleworth's work exemplifies the spirit of innovation in the pharmaceutical industry. His patents and collaborations highlight his commitment to improving health outcomes through scientific advancements. His contributions continue to pave the way for future developments in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
